EIF2A and Parkinson disease: Studies have demonstrated that GSK2606414 effectively inhibits the PERK-eIF2α axis, thereby attenuating neuronal apoptosis induced by endoplasmic reticulum stress, improving neuropathological damage, memory, and motor function impairments, and preventing neurodegeneration in Parkinson’s disease model [39].